Chronic Migraine Study - Botox
Living with a constant shadow of pain is exhausting. For those dealing with at least 15 headache days every month, finding a reliable Botox migraine solution is often the highest priority. At Lone Star Neurology in Texas, we are currently enrolling participants for the MINT-C clinical study – a structured research program focused on Xeomin (incobotulinumtoxinA), a purified neurotoxin similar to standard Botox but with a slightly different molecular structure.
The primary goal of this study is to measure the change in monthly migraine days when using Xeomin compared to a placebo. Participants receive injections into specific muscles of the head and neck over approximately 52 to 55 weeks. The study aims to generate meaningful new data on chronic migraine treatment options for patients who have not found sufficient relief through existing therapies.
Are you tired of the relentless cycle of pain and ready to explore a new path? The MINT-C study offers a professionally supervised, structured environment to do exactly that. We invite eligible patients to apply today and help us advance the science of headache relief.
What Is Chronic Migraine?
Most people have experienced a headache at some point in their lives. But chronic migraine is an entirely different condition – one that demands serious, specialized treatment. To receive this diagnosis, a patient must experience at least 15 headache days per month for more than three consecutive months. Of those 15 days, at least 8 must meet the specific clinical criteria for a migraine episode. This is not ordinary tension or stress-related head pain. It involves:
Intense, throbbing pain – often on one side of the head
Debilitating sensitivity to light and sound
Nausea that can make normal functioning impossible
There is a significant clinical distinction between Botox chronic migraine candidates and those with episodic attacks, where a person might experience only a few episodes per month. When a patient reaches the chronic stage, the condition begins to dictate every aspect of daily life. It undermines performance at work, forces the cancellation of social plans, and places real strain on family relationships. Many patients describe feeling as though they live in a permanent “waiting room” for the next attack.
Effective chronic migraine treatment is not simply about managing pain in the moment. It is about reclaiming the ability to live a normal, predictable, and fulfilling life.
About the MINT-C Chronic Migraine Research Study
The MINT-C study is a specialized research program designed to rigorously evaluate how effectively Xeomin reduces the frequency of attacks in patients who suffer from chronic migraine. During the study, participants are randomly assigned to receive either Xeomin or a placebo, administered via injection into the muscles of the head and neck. By carefully comparing both groups, researchers can determine with scientific precision whether the medication produces a meaningful reduction in monthly migraine days.
Throughout the study, you will work closely with our dedicated medical team. The full protocol spans approximately 52 to 55 weeks and includes regularly scheduled clinic visits during which board-certified headache specialists treat Botox migraine injection sites. Between visits, participants are asked to maintain a daily electronic headache diary – a vital component of the research that provides a real-time record of symptoms and their evolution.
Participation is entirely voluntary, and you may withdraw at any point without penalty. Your involvement, however, directly contributes to a body of evidence that could reshape Botox migraine treatment protocols for millions of sufferers around the world.
Who May Be Eligible?
Not every patient with a headache disorder qualifies for a clinical trial. Strict eligibility protocols are in place to ensure the integrity of the data and the safety of every participant. To be considered for the MINT-C study, candidates must meet the following criteria:
- You are at least 18 years of age
- Your first migraine episode began before the age of 50
- You have a documented history of at least 15 headache days per month
- At least 8 of those days per month meet clinical migraine criteria
- You have experienced at least 3 headache-free days in each of the last 3 months
A question many patients ask when exploring Botox for migraine therapies is: how many units of botox for migraines are typically administered in a single session? In standard clinical practice, approximately 155 units are injected across multiple sites in the head and neck. The MINT-C study follows a precise, protocol-defined dosing regimen for Xeomin, which may differ slightly from routine treatment.
It is important to note that final eligibility is never determined solely by a checklist. Our study team at Lone Star Neurology will conduct a thorough, individualized screening process to confirm that participation is both safe and appropriate for you.
What to Expect as a Study Participant
Joining a clinical study is a journey that begins with a careful screening process. First, our team will review your complete medical history and current symptom profile. If you meet the initial criteria, you will enter a baseline observation period during which you track your headaches daily to establish a reliable starting point for comparison.
Once the baseline period is complete, the treatment phase begins. You will receive either Xeomin or a placebo delivered as a Botox migraine treatment into the targeted muscles of the head and neck. These visits are always conducted by board-certified neurologists who specialize in headache medicine. You are not simply a number in a database – you are a patient under high-level neurological care.
Alongside the injection visits, you will continue maintaining your electronic diary to log daily experiences and symptom changes. Regular assessments and check-ins ensure that your health is closely monitored throughout the study. This level of individualized attention is often far more comprehensive than what patients receive during standard routine consultations – and it comes at no cost to you.
Benefits and Risks of Participation
Every medical study involves a careful balance of potential benefits and realistic risks, and we believe in complete transparency with every participant.
On the benefits side, participants receive access to an investigational Botox migraine therapy using Xeomin at absolutely no personal cost. You also benefit from intensive neurological monitoring, regular specialist consultations, and the meaningful satisfaction of contributing to the future of medicine. For many patients, the opportunity to potentially reduce their monthly migraine days – and genuinely reclaim their quality of life – is the most powerful motivator of all.
On the risk side, it is important to approach participation with informed expectations. As with any injection-based therapy, there are Botox migraine side effects to be aware of. These are generally mild and consistent with the established safety profile of the drug class. Some participants may experience:
- Temporary redness or bruising at the injection site
- Mild, transient muscle weakness in the neck or shoulders
- A sensation of heaviness in the forehead area
- Neck discomfort or a mild headache immediately following the procedure
Our team will discuss every potential risk in full detail during the informed consent process, ensuring you have everything you need to make a confident, well-informed decision about your health.
How to Apply - Contact Lone Star Neurology
If you are tired of living in the shadow of chronic pain and want to find out whether you qualify for a migraine clinical trial, the process is straightforward. We are actively enrolling participants and would welcome the opportunity to speak with you.
You can complete our “Click to Apply” form directly on our website. The form includes a brief set of screening questions:
- Your name
- Contact information (phone and email)
- Have you been diagnosed with chronic migraine for at least 12 months?
- Can you reliably distinguish a migraine from other headache types?
- Did your headaches begin before the age of 50?
- Are you willing to use an electronic diary daily?
Once your form is submitted, a study coordinator will contact you promptly to discuss the next steps and address any questions you may have. If you prefer to speak with someone directly, please call us at 214-619-1910. For those who wish to review the full technical details, our study is listed on ClinicalTrials.gov under identifier NCT07018700.
Searching for a clinical trial near me can be the first meaningful step toward a fundamentally different approach to managing your condition. At Lone Star Neurology, we are committed to finding better, more effective solutions for Botox migraine sufferers across Texas – and we are here to support you through every stage of that journey. Reach out today to see if the MINT-C study is the right fit for you.
